Contrast Shortage

Updated: May 23, 2022

Due to a global shortage of iodinated contrast, used primarily for CT scans, clinicians should limit contrasted CT orders to necessary cases which cannot be deferred.

Background information:

In April 2022, a COVID-19-related lockdown in Shanghai, China stopped production of Omnipaque (iohexol) at a major GE Healthcare production plant, disrupting supply chains and resulting in a global shortage of all types of ICM. GE Healthcare notified customers to expect an 80% reduction in order fulfillment that may last 6-8 weeks.

Current Status:

Yellow

Criteria:

Alternate Exams Resource - ACR Appropriate Use Criteria
Please see the link below regarding iodinated contrast-free alternative exam options, such as ultrasound, MRI and PET/CT.
ACR-Appropriateness-Criteria

Frequently Asked Questions:

For Patients

For Providers

Resources and News Articles:

Statement from the ACR Committee on Drugs and Contrast Media

Alabama Board of Medical Examiners

Reuters News Article

NBC News Article